Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PDSHeart was a leading provider of remote cardiac monitoring services and diagnostic technologies, specializing in solutions for patients with suspected heart rhythm disorders. The company offered a comprehensive suite of services, including mobile cardiac outpatient telemetry (MCOT), cardiac event monitoring, and Holter monitoring. By utilizing advanced telemetric technology, PDSHeart enabled physicians to monitor patients' cardiac activity in real-time, facilitating the diagnosis of arrhythmias such as atrial fibrillation. In 2007, the company was acquired by CardioNet for approximately $50 million, creating a dominant force in the wireless cardiac monitoring market. Its operations were eventually integrated into BioTelemetry, which was subsequently acquired by Philips in 2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PDSHeart.